KHAN TECHNOLOGY TRANSFER FUND

The KHAN-I fund is managed by Khanu Management GmbH, an experienced team of professionals with proven track records in early-stage drug discovery & development, academic spin-offs as well as pharma licensing and partnering... KHAN Technology Transfer Fund I (KHAN-I) is an early-stage life sciences venture fund with 70 millions under management. Our mission is to create value through cooperative drug development partnerships with academic innovators in Europe. KHAN-I focuses on first-in-class therapies for attractive markets with a high unmet medical need... In order to close the gap in translating science into products and to help scientific discoveries to unfold their full potential, KHAN-I operates in close partnership with the Lead Discovery Center GmbH (LDC) in Dortmund and Munich. The LDC is a fully operational drug discovery incubator with an established broad academic and industrial network. It provides state-of-the art drug discovery services in accordance with industry..

Also known as: Khanu Management GmbH

Primary location: Dortmund Germany